[1]
Xu, Y. 2026. Predictive Value of Tumor-Infiltrating Lymphocytes for Neoadjuvant Chemotherapy Among Triple-Negative Breast Cancer. International Journal of Biology and Life Sciences. 17, 2 (Nov. 2026), 32–36. DOI:https://doi.org/10.54097/j931ky70.